 The award enables rapid development of mRNA vaccine targeted to various influenza virus subtypes or strains with pandemic potential. Development and manufacturing can pivot quickly if needed to address other emerging infectious diseases. You got to love that last sentence. Development and manufacturing can pivot quickly. Why? Well, it might not be bird flu.